Summary: Andrew Jack, the FT's Pharmaceutical correspondent, talks to Rifat Atun, director; strategy, performance and evaluation cluster; the Global Fund to fight Aids, TB and Malaria
Summary: Andrew Jack, the FT's Pharmaceutical correspondent, talks to Rifat Atun, director; strategy, performance and evaluation cluster; the Global Fund to fight Aids, TB and Malaria